Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
AVANOS MEDICAL, INC. (AVNS) had Cost of Goods Sold of $293.60M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$673.30M |
|
$-61.80M |
|
|
Cost of Goods Sold |
$293.60M |
$379.70M |
|
$669.10M |
|
$4.20M |
|
$-12.10M |
|
$-7.90M |
|
$-7.90M |
|
$-9.90M |
|
$-9.90M |
|
$-61.80M |
|
$-9.90M |
|
$4.20M |
|
$50.30M |
|
46.60M |
|
46.60M |
|
$-1.32 |
|
$-1.32 |
|
| Balance Sheet Financials | |
$487.00M |
|
$117.20M |
|
$1.21B |
|
$1.69B |
|
$234.60M |
|
$159.40M |
|
$221.50M |
|
$456.10M |
|
$1.24B |
|
$200.70M |
|
$1.24B |
|
46.17M |
|
| Cash Flow Statement Financials | |
$32.40M |
|
$21.60M |
|
$-94.20M |
|
$127.70M |
|
$87.70M |
|
$-40.00M |
|
$15.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.08 |
|
-- |
|
-- |
|
0.11 |
|
0.14 |
|
56.39% |
|
0.62% |
|
0.62% |
|
7.47% |
|
-1.17% |
|
-9.18% |
|
$14.60M |
|
-- |
|
-- |
|
-- |
|
0.40 |
|
1.80 |
|
4.71 |
|
77.41 |
|
-0.80% |
|
-4.93% |
|
-0.58% |
|
-0.71% |
|
$26.77 |
|
$0.31 |
|
$0.70 |
|